High initial HIV/AIDS-Related mortality and -its predictors among patients on antiretroviral therapy in the kagera region of Tanzania: A five-year retrospective cohort study

AIDS Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Mageda, Kihulya ^a   Leyna, Germana Henry ^b   Mmbaga, Elia John ^b  

^a Biharamulo District Council   (Tanzania)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873873781     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2012/843598     Document Type: Article

References (25)

1. UNAIDSW, UNICEF, Global HIV/AIDS response: epidemic update and health sector progress towards universal access. Progress Report 2010 Geneva, Switzerland United Nation Joint Programme on AIDS
2. Egger M., Hirschel B., Francioli P., Sudre P., Wirz M., Flepp M., Rickenbach M., Malinverni R., Vernazza P., Battegay M., Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. British Medical Journal 1997 315 7117 1194 1199 2-s2.0-9844238154 (Pubitemid 27478210)
3. Jevtović D. J., Salemović D., Ranin J., Pešić I., Žerjav S., Djurković-Djaković O., The prevalence and risk immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy. HIV Medicine 2005 6 2 140 143 2-s2.0-15844397256 10.1111/j.1468-1293.2005.00277.x (Pubitemid 40425979)
4. Palella F. J., Delaney K. M., Moorman A. C., Loveless M. O., Fuhrer J., Satten G. A., Aschman D. J., Holmberg S. D., Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. The New England Journal of Medicine 1998 338 13 853 860 2-s2.0-2642709177 10.1056/NEJM199803263381301 (Pubitemid 28135961)
5. NBS, AIDS and Malaria indicators surveys 2007-2008. TACAIDS 2009 Dar es Salaam, Tanzania National Bureau of Statistics
6. Sieleunou I., Souleymanou M., Schönenberger A. M., Menten J., Boelaert M., Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North province, Cameroon. Tropical Medicine and International Health 2009 14 1 36 43 2-s2.0-58449128230 10.1111/j.1365-3156. 2008.02183.x
7. Dias S. S., Andreozzi V., Martins M. O., Torgal J., Predictors of mortality in HIV-associated hospitalizations in Portugal: a hierarchical survival model. BMC Health Services Research 2009 9, article 125 7 2-s2.0-69049089830 10.1186/1472-6963-9-125
8. Gorgos L., Avery E., Bletzer K., Wilson C., Determinants of survival for native American adults with HIV infection. AIDS Patient Care and STDs 2006 20 8 586 594 2-s2.0-33748866303 10.1089/apc.2006.20.586 (Pubitemid 44769206)
9. Brinkhof M. W. G., Dabis F., Myer L., Bangsberg D. R., Boulle A., Nash D., Schechter M., Laurent C., Keiser O., May M., Sprinz E., Egger M., Anglaret X., Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bulletin of the World Health Organization 2008 86 7 559 567 2-s2.0-46449097695 10.2471/BLT.07.044248 (Pubitemid 351931216)
10. Jerene D., Endale A., Hailu Y., Lindtjøorn B., Predictors of early death in a cohort of Ethiopian patients treated with HAART. BMC Infectious Diseases 2006 6, article 136 7 2-s2.0-33748900460 10.1186/1471-2334-6-136 (Pubitemid 44426195)
11. Steegen K., Luchters S., Dauwe K., Reynaerts J., Mandaliya K., Jaoko W., Plum J., Temmerman M., Verhofstede C., Effectiveness of antiretroviral therapy and development of drug resistance in HIV-1 infected patients in Mombasa, Kenya. AIDS Research and Therapy 2009 6, article 12 4 2-s2.0-67650261866 10.1186/1742-6405-6-12
12. Marconi V. C., Grandits G. A., Weintrob A. C., Chun H., Landrum M. L., Ganesan A., Okulicz J. F., Crum-Cianflone N., O'Connell R. J., Lifson A., Wortmann G. W., Agan B. K., Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History study. AIDS Research and Therapy 2010 7, article 14 10 2-s2.0-77952737410 10.1186/1742-6405-7-14
13. Andinet W., Sebastian M. S., Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia. Global Health Action 2010 5398 3 1 10
14. Johannessen A., Naman E., Ngowi B. J., Sandvik L., Matee M. I., Aglen H. E., Gundersen S. G., Bruun J. N., Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infectious Diseases 2008 8, article 52 2-s2.0-42949113959 10.1186/1471-2334-8-52 (Pubitemid 351619259)
15. Abaasa A. M., Todd J., Ekoru K., Kalyango J. N., Levin J., Odeke E., Karamagi C. A. S., Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of the AIDS Support Organization (TASO), Kampala, Uganda. BMC Health Services Research 2008 8, article 241 2-s2.0-58149085677 10.1186/1472-6963-8-241
16. Sanne I. M., Westreich D., Macphail A. P., Long term outcomes of antiretroviral therapy in a lager HIV/AIDS care clinic in urban South Africa: a prospective cohort study. Journal of the International AIDS Society 2009 17 12, article 38
17. Coetzee D., Hildebrand K., Boulle A., Maartens G., Louis F., Labatala V., Reuter H., Ntwana N., Goemaere E., Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004 18 6 887 895 2-s2.0-2142764446 10.1097/00002030-200404090-00006 (Pubitemid 38553709)
18. Moore D. M., Awor A., Downing R. S., Were W., Solberg P., Tu D., Chan K., Hogg R. S., Mermin J., Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index. AIDS Research and Therapy 2007 4, article 1 7 2-s2.0-33847178318 10.1186/1742-6405-4-1
19. Grigoryan A., Hall H. I., Durant T., Wei X., Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004. PLoS ONE 2009 4 2 2-s2.0-61849094259 10.1371/journal.pone.0004445 e4445
20. Lawn S. D., Harries A. D., Anglaret X., Myer L., Wood R., Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008 22 15 1897 1908 2-s2.0-53549132522 10.1097/QAD. 0b013e32830007cd
21. Nakanjako D., Kiragga A., Ibrahim F., Castelnuovo B., Kamya M. R., Easterbrook P. J., Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on Antiretroviral Therapy (ART) in sub-Saharan Africa: frequency and clinical significance. AIDS Research and Therapy 2008 5, article 23 9 2-s2.0-58149100332 10.1186/1742-6405-5-23
22. Geng E. H., Hunt P. W., Diero L. O., Kimaiyo S., Somi G. R., Okong P., Bangsberg D. R., Bwana M. B., Cohen C. R., Otieno J. A., Wabwire D., Elul B., Nash D., Easterbrook P. J., Braitstein P., Musick B. S., Martin J. N., Yiannoutsos C. T., Wools-Kaloustian K., Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009. Journal of the International AIDS Society 2011 14, article 46
23. Egger M., May M., Chêne G., Phillips A. N., Ledergerber B., Dabis F., Costagliola D., D'Arminio Monforte A., De Wolf F., Reiss P., Lundgren J. D., Justice A. C., Staszewski S., Leport C., Hogg R. S., Sabin C. A., Gill M. J., Salzberger B., Sterne J. A. C., Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. The Lancet 2002 360 9327 119 129 2-s2.0-0037072066 10.1016/S0140- 6736(02)09411-4 (Pubitemid 34786200)
24. Alibhai A., Kipp W., Saunders L. D., Senthilselvan A., Kaler A., Houston S., Konde-Lule J., Okech-Ojony J., Rubaale T., Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda. International Journal of Women's Health 2010 2 1 45 52 2-s2.0-77953388331
25. Kouanda S., Meda I. B., Nikiema L., Tiendrebeogo S., Doulougou B., Kaboré I., Sanou M. J., Greenwell F., Soudré R., Sondo B., Determinants and causes of mortality in HIV-infected patients receiving antiretroviral therapy in Burkina Faso: a five-year retrospective cohort study. AIDS Care 2011 24 4 478 490